Alisertib in Chemotherapy-pretreated Urothelial Cancer

Clinical trial NCT02109328 · COMPLETED

Trial details

NCT number: NCT02109328
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Transitional Cell Carcinoma

Start date: 2014-08-28
Primary completion: 2015-07-02
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.